X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
medical and health sciences (103) 103
medicin och hälsovetenskap (103) 103
clinical medicine (48) 48
klinisk medicin (48) 48
humans (45) 45
index medicus (43) 43
immunotherapy (36) 36
medicine (34) 34
cancer and oncology (33) 33
cancer och onkologi (33) 33
immunology (33) 33
animals (30) 30
medicin (30) 30
basic medicine (27) 27
medicinska och farmaceutiska grundvetenskaper (27) 27
oncology (27) 27
cancer (23) 23
mice (23) 23
female (22) 22
male (21) 21
mice, inbred c57bl (20) 20
gene therapy (18) 18
hematology (18) 18
immunologi inom det medicinska området (18) 18
immunology in the medical area (18) 18
medicine, research & experimental (16) 16
cd40 ligand - genetics (15) 15
cell line, tumor (15) 15
t cells (15) 15
chemistry (14) 14
metallurgy (14) 14
organic chemistry (14) 14
peptides (14) 14
adenoviridae - genetics (13) 13
human necessities (13) 13
hygiene (13) 13
medical or veterinary science (13) 13
preparations for medical, dental, or toilet purposes (13) 13
dendritic cells (12) 12
flow cytometry (12) 12
hematologi (12) 12
chronic lymphocytic-leukemia (11) 11
immunologi (11) 11
middle aged (11) 11
tumors (11) 11
urinary bladder neoplasms - immunology (11) 11
adult (10) 10
biotechnology & applied microbiology (10) 10
care and treatment (10) 10
microbiology (10) 10
urinary bladder neoplasms - therapy (10) 10
adenovirus (9) 9
apoptosis (9) 9
beer (9) 9
biochemistry (9) 9
bladder-cancer (9) 9
enzymology (9) 9
genetic therapy - methods (9) 9
in-vivo (9) 9
medical biotechnology (9) 9
medicinsk bioteknologi (9) 9
mutation or genetic engineering (9) 9
research (9) 9
spirits (9) 9
t-lymphocytes, regulatory - immunology (9) 9
therapy (9) 9
vinegar (9) 9
wine (9) 9
aged (8) 8
antitumor immunity (8) 8
cd40 ligand - immunology (8) 8
cd40l (8) 8
expression (8) 8
genetic vectors (8) 8
genetics & heredity (8) 8
medical biotechnology, molecular biology, microbiology, biochemistry or biopharmacy (8) 8
medicinsk bioteknologi, molekylärbiologi, mikrobiologi, biokemi eller biofarmaci (8) 8
regulatory t-cells (8) 8
suppressor-cells (8) 8
t regulatory cells (8) 8
t-lymphocytes - immunology (8) 8
cancer-patients (7) 7
cd40 ligand (7) 7
compositions thereof (7) 7
culture media (7) 7
cytokines (7) 7
genetic therapy (7) 7
lymphocytes (7) 7
lymphocytes t (7) 7
microorganisms or enzymes (7) 7
multiple sclerosis (7) 7
neurology (7) 7
propagating, preserving or maintaining microorganisms (7) 7
activation (6) 6
adcd40l (6) 6
adoptive immunotherapy (6) 6
biochemistry & molecular biology (6) 6
bladder cancer (6) 6
carcinoma (6) 6
genetic engineering (6) 6
more...
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


PLoS ONE, ISSN 1932-6203, 01/2013, Volume 8, Issue 1, p. e55818
Immunotherapy (eg interferon alpha) in combination with tyrosine kinase inhibitors is currently in clinical trials for treatment of chronic myeloid leukemia... 
CHRONIC MYELOGENOUS LEUKEMIA | CANCER-PATIENTS | B7-H1 PD-L1 | TUMOR BURDEN | MULTIDISCIPLINARY SCIENCES | HEPATOCELLULAR-CARCINOMA PATIENTS | IMATINIB | INTERLEUKIN-2 RECEPTOR | PHASE-I | T-CELLS | CLINICAL-SIGNIFICANCE | Antigens, CD34 - metabolism | Humans | Middle Aged | Arginase - metabolism | Leukemia, Myelogenous, Chronic, BCR-ABL Positive - genetics | Male | Programmed Cell Death 1 Receptor - antagonists & inhibitors | Young Adult | Lymphocyte Activation - immunology | T-Lymphocytes - metabolism | Myeloid Cells - immunology | Adult | Female | Leukemia, Myelogenous, Chronic, BCR-ABL Positive - immunology | Interleukin-2 Receptor alpha Subunit - blood | Programmed Cell Death 1 Receptor - metabolism | Gene Expression Regulation, Leukemic | B7-H1 Antigen - metabolism | Interleukin-2 Receptor alpha Subunit - metabolism | Adolescent | Cell Line, Tumor | Leukemia, Myelogenous, Chronic, BCR-ABL Positive - metabolism | Myeloid Cells - metabolism | T-Lymphocytes - immunology | Aged | Programmed Cell Death 1 Receptor - genetics | Medical research | Care and treatment | Immunotherapy | Medicine, Experimental | Development and progression | Interferon | Chronic myeloid leukemia | T cells | Risk factors | Cancer | Cell proliferation | Disease | PD-1 protein | Laboratories | Leukemia | Science | Clinical trials | Risk | Arginase | Lymphocytes T | Kinases | Suppressor cells | Ethics | Immunology | Interleukin 2 | Lymphocytes | Cell cycle | CD25 antigen | Protein-tyrosine kinase | Immune system | Tyrosine | CD34 antigen | Myeloid cells | Cytokines | Hematology | Secretion | Myeloid leukemia | Mortality | Blood banks | Patients | Studies | Pathology | Hospitals | Medical prognosis | PD-L1 protein | Stem cells | Ligands | Death | Lymphomas | Apoptosis | Clinical Medicine | Medical and Health Sciences | Cancer and Oncology | Klinisk medicin | Medicin och hälsovetenskap | Cancer och onkologi
Journal Article
Journal of Neuroinflammation, ISSN 1742-2094, 05/2012, Volume 9, Issue 1, pp. 112 - 112
Background: Multiple sclerosis (MS) is an autoimmune disease of the central nervous system (CNS). In the murine experimental autoimmune encephalomyelitis (EAE)... 
EAE | Redirected cells | FoxP3 | Myelin oligodendrocyte glycoprotein (MOG) | T regulatory cells | EXPERIMENTAL AUTOIMMUNE ENCEPHALOMYELITIS | STEM-CELLS | TGF-BETA | redirected cells | TOLERANCE | NEUROSCIENCES | CUTTING EDGE | MYELIN OLIGODENDROCYTE GLYCOPROTEIN | MULTIPLE-SCLEROSIS | CENTRAL-NERVOUS-SYSTEM | GENE-THERAPY | T-Lymphocytes, Regulatory - metabolism | Central Nervous System - metabolism | Genetic Vectors - administration & dosage | Lentivirus - immunology | Encephalomyelitis, Autoimmune, Experimental - immunology | Central Nervous System - immunology | T-Lymphocytes, Regulatory - immunology | Cell Engineering - methods | Female | Lentivirus - genetics | Encephalomyelitis, Autoimmune, Experimental - genetics | Cell Line | Gene Transfer Techniques | Genetic Vectors - immunology | Mice, Inbred C57BL | Forkhead Transcription Factors - genetics | Administration, Intranasal | Encephalomyelitis, Autoimmune, Experimental - therapy | Animals | Receptors, Antigen, T-Cell - administration & dosage | Mice | Receptors, Antigen, T-Cell - genetics | T-Lymphocytes, Regulatory - transplantation | Forkhead Transcription Factors - administration & dosage | Genetic Therapy - methods | Animal experimentation | Antigens | Medical equipment and supplies industry | Multiple sclerosis | Medical test kit industry | Central nervous system | T cells | Gene mutations | Genetically modified organisms | Genetic engineering | Cellular signal transduction | Myelin proteins | Clinical Medicine | Neurology | Neurologi | Medical and Health Sciences | Medicin och hälsovetenskap | Klinisk medicin | myelin oligodendrocyte glycoprotein | MS
Journal Article
Human Gene Therapy, ISSN 1043-0342, 08/2015, Volume 26, Issue 8, pp. 498 - 505
Journal Article
Immunology, ISSN 0019-2805, 04/2012, Volume 135, Issue 4, pp. 255 - 260
Journal Article
Immunology, ISSN 0019-2805, 11/2010, Volume 131, Issue 3, pp. 371 - 376
Summary Interleukin‐2 (IL‐2) is one of the most studied cytokines driving T‐cell proliferation, activation and survival. It binds to the IL‐2 receptor... 
T regulatory cell | immune escape mechanism | CD25 | interleukin‐2 receptor α | B‐cell malignancy | Interleukin-2 receptor α | Immune escape mechanism | B-cell malignancy | INTERLEUKIN-2-RECEPTOR | TUMOR | RECEPTOR | IL-2 | LEVEL | IMMUNOLOGY | CANCER | interleukin-2 receptor alpha | NON-HODGKINS-LYMPHOMA | T-Lymphocyte Subsets - immunology | Tumor Escape - drug effects | T-Lymphocytes, Regulatory - metabolism | Lymphoma, B-Cell - blood | Humans | T-Lymphocytes, Regulatory - pathology | T-Lymphocytes, Regulatory - immunology | Flow Cytometry | Interleukin-2 Receptor alpha Subunit - genetics | Lymphoma, B-Cell - immunology | Interleukin-2 Receptor alpha Subunit - immunology | Tumor Escape - immunology | Recombinant Proteins - metabolism | Forkhead Transcription Factors - biosynthesis | Enzyme-Linked Immunosorbent Assay | Interleukin-2 Receptor alpha Subunit - blood | Cell Separation | Cells, Cultured | Recombinant Proteins - genetics | T-Lymphocyte Subsets - pathology | Interleukin-2 Receptor alpha Subunit - metabolism | Recombinant Proteins - immunology | T-Lymphocyte Subsets - metabolism | Lymphoma, B-Cell - pathology | Cell Proliferation - drug effects | Care and treatment | Non-Hodgkin's lymphomas | T cells | Enzyme-linked immunosorbent assay | Cancer | Cell growth | Medical prognosis | T cell receptors | Original | interleukin-2 receptor α | Immunologi | Immunology | Medical and Health Sciences | Medicin och hälsovetenskap | MEDICIN | MEDICINE
Journal Article
Immunology, ISSN 0019-2805, 07/2014, Volume 142, Issue 3, pp. 431 - 441
Journal Article
Clinical Cancer Research, ISSN 1078-0432, 10/2017, Volume 23, Issue 19, pp. 5846 - 5857
Purpose: Pancreatic cancer is a severe indication with short expected survival despite surgery and/or combination chemotherapeutics. Checkpoint blockade... 
TRIAL | ADVANCED SOLID TUMORS | THERAPY | NK CELLS | ONCOLOGY | METASTATIC PANCREATIC ADENOCARCINOMA | RECEPTOR | MELANOMA PATIENTS | PHASE-I | CANCER | ADENOVIRUS | CD40 Antigens - antagonists & inhibitors | Killer Cells, Natural - virology | Dendritic Cells - immunology | Humans | Pancreatic Neoplasms - pathology | Tumor Necrosis Factor Receptor Superfamily, Member 9 - immunology | Oncolytic Viruses - genetics | Tumor Necrosis Factor Receptor Superfamily, Member 9 - genetics | Cell Movement - immunology | Xenograft Model Antitumor Assays | Oncolytic Virotherapy - methods | Signal Transduction - immunology | Lymphocyte Activation - immunology | Animals | Oncolytic Viruses - immunology | Pancreatic Neoplasms - immunology | Adenoviridae - genetics | Cell Line, Tumor | Killer Cells, Natural - immunology | Mice | Dendritic Cells - virology | CD40 Antigens - immunology | Pancreatic Neoplasms - therapy | Pancreatic Neoplasms - virology | Flow cytometry | Collagen (type I) | CD40 antigen | Gemcitabine | Leukocyte migration | Antibodies | Viruses | Lymphocytes T | Immunity | CD40L protein | Lymphocytes | Surgery | Xenografts | Oncolysis | Immune system | Stellate cells | Immunostimulation | Cytokines | Dendritic cells | Tumor cells | Stroma | Endothelial cells | Cytometry | Signaling | Immune checkpoint | Experimental design | Pancreatic cancer | Proteomics | Cell lines | Antitumor activity | Chemokines | Cell migration | Tumors | Cancer | Clinical Medicine | Medical Biotechnology | Medical and Health Sciences | Medicin och hälsovetenskap | Medicinsk bioteknologi | Cancer and Oncology | Klinisk medicin | Medical Biotechnology (with a focus on Cell Biology (including Stem Cell Biology), Molecular Biology, Microbiology, Biochemistry or Biopharmacy) | Medicinsk bioteknologi (med inriktning mot cellbiologi (inklusive stamcellsbiologi), molekylärbiologi, mikrobiologi, biokemi eller biofarmaci) | Cancer och onkologi
Journal Article
Immunology, ISSN 0019-2805, 07/2011, Volume 133, Issue 3, pp. 296 - 306
Journal Article
Clinical Cancer Research, ISSN 1078-0432, 12/2005, Volume 11, Issue 24, pp. 8816 - 8821
Journal Article
Journal Article
Clinical Cancer Research, ISSN 1078-0432, 06/2010, Volume 16, Issue 12, pp. 3279 - 3287
Journal Article